Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-19

Clinical Trial Update: Sirolimus in Treatment of Proteinuric Flares of Lupus Nephritis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial evaluating sirolimus for treatment of proteinuric flares in lupus nephritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sirolimus (Sirolimus)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Lupus Nephritis, Immunosuppression | Phase 2, Phase 3 | Status: UNKNOWN